FDA Inspection 1021141 — Merz Pharma GmbH & Co., KGaA
The FDA completed an inspection of Merz Pharma GmbH & Co., KGaA on July 4, 2017 in Dessau-Rosslau. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- July 4, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Dessau-Rosslau (Germany)